Journal
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
Volume 213, Issue 4, Pages S197-S206Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.ajog.2015.07.010
Keywords
cell-free deoxyribonucleic acid; cell-free messenger ribonucleic acid; microribonucleic acid; pregnancy complications; screening
Categories
Funding
- Canadian Institutes of Health Research [49520]
Ask authors/readers for more resources
During pregnancy, the placenta releases a variety of nucleic acids (including deoxyribonucleic acid, messenger ribonucleic acid, or microribonucleic acids) either as a result of cell turnover or as an active messaging system between the placenta and cells in the maternal body. The profile of released nucleic acids changes with the gestational age and has been associated with maternal and fetal parameters. It also can directly reflect pathological changes in the placenta. Nucleic acids may therefore provide a rich source of novel biomarkers for the prediction of pregnancy complications. However, their utility in the clinical setting depends, first, on overcoming some technical considerations in their quantification, and, second, on developing a better understanding of the factors that influence their function and abundance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available